中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
近代物理研究所 [76]
高能物理研究所 [49]
上海药物研究所 [22]
国家天文台 [13]
心理研究所 [12]
动物研究所 [11]
更多
采集方式
OAI收割 [253]
iSwitch采集 [43]
_filter
_filter
_filter
筛选
浏览/检索结果:
共296条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Design, Synthesis, and biological evaluation of 7H-Pyrrolo[2,3-d] pyrimidines as potent HPK1 kinase inhibitors
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY, 2025, 卷号: 119, 页码: 13
作者:
Wu, Feifei
;
Li, Huiyu
;
Li, Weiqiang
;
Zhang, Laishun
;
An, Qi
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2025/04/01
Optimization
Hematopoietic progenitor kinase 1
Inhibitor
Cancer immunotherapy
Nonlinear dynamic analysis and vibration reduction of two sandwich beams connected by a joint with clearance
期刊论文
OAI收割
MECHANICAL SYSTEMS AND SIGNAL PROCESSING, 2025, 卷号: 223, 页码: 24
作者:
Guo, Zhenkun
;
Jiang, Shuai
;
Shen, Yongjun
;
Jiang, Guoqing
;
Xiao, Boya
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2024/10/08
Interconnect sandwich beam
Equivalent joint model
Rayleigh-Ritz method
Clearance
Enhanced Antitumor Immunity of a Globo H-Based Vaccine Enabled by the Combination Adjuvants of 3D-MPL and QS-21
期刊论文
OAI收割
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 页码: 11
作者:
Ma, Wenjing
;
Xu, Zhuojia
;
Teng, Changcai
;
Cao, Chang
;
Wu, Ruixue
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2025/04/01
Carbohydrates
oligosaccharide synthesis
synthesis design
carbohydrate-based vaccines
immunological activity
Chemical profiling and comparative analysis of different parts of
Asarum
heterotropoides
using SPME-GC-QTOF-MS and LC- Orbitrap-MS
期刊论文
OAI收割
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2025, 卷号: 252, 页码: 9
作者:
Hu, Yun-shu
;
Zhang, Jian-qing
;
Xu, Meng
;
Yang, Huan-ya
;
Liu, Chun-xiang
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2024/11/26
Asari radix et rhizoma
A. heterotropoides
SPME-GC-MS
LC-Orbitrap-MS
Comprehensive multi-omics analysis elucidates colchicine-induced toxicity mechanisms and unveils the therapeutic potential of MLN4924 and kinase inhibitors
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2024, 页码: 13
作者:
Zhai, Lin-hui
;
Jia, Xing-long
;
Chen, Yu-lu
;
Liu, Mu-yin
;
Zhang, Jing-dan
  |  
收藏
  |  
浏览/下载:76/0
  |  
提交时间:2024/12/25
colchicine
MLN4924
multi-omics analysis
phosphoproteomics
ubiquitinomics
kinase inhibitor
Cost assessment and potential evaluation of geologic carbon storage in China based on least-cost path analysis
期刊论文
OAI收割
APPLIED ENERGY, 2024, 卷号: 371, 页码: 18
作者:
Xu, Xiaoyi
;
Li, Qi
;
Cai, Bofeng
;
Liu, Guizhen
;
Pang, Lingyun
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2025/06/27
CCUS
Source -sink matching
Cost assessment
Least -cost path analysis
Storage potential
CO 2 geological storage
Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer
期刊论文
OAI收割
ISCIENCE, 2024, 卷号: 27
作者:
Zhu, Qizhi
;
Fu, Meng
;
Qi, Jian
;
Xu, Ziming
;
Wang, Yongguang
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2024/11/22
Medcheck: a novel software for automated de-formulation of traditional Chinese medicine (TCM) prescriptions by liquid chromatography-mass spectrometry
期刊论文
OAI收割
JOURNAL OF PHARMACEUTICAL ANALYSIS, 2024, 卷号: 14, 期号: 6, 页码: 3
作者:
Li, Xiao-lan
;
Zhang, Jian-qing
;
Li, Yun
;
Shen, Xuan-jing
;
Yang, Huan-ya
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2024/08/22
Study on failure characteristics and evaluation index of aquifer shale based on energy evolution
期刊论文
OAI收割
ACTA GEOTECHNICA, 2024, 页码: 20
作者:
Qi, Xian-yin
;
Geng, Dian-dong
;
Feng, Meng-yao
;
Xu, Ming-zhe
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2025/06/27
Energy evolution
Laminated shale
Moisture content
Mechanical test
Well stability
Structure-based development of potent and selective type-II kinase inhibitors of RIPK1
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2024, 卷号: 14, 期号: 1, 页码: 319-334
作者:
Qin, Ying
;
Li, Dekang
;
Qi, Chunting
;
Xiang, Huaijiang
;
Meng, Huyan
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2024/03/06
RIPK1
Necroptosis
Type-II kinase inhibitors
Rational design
Lead optimization
Structure-activity relationship
Anti-inflammation
Preclinical drug discovery